[HTML][HTML] Stem cell-based therapy for human diseases
DM Hoang, PT Pham, TQ Bach, ATL Ngo… - Signal transduction and …, 2022 - nature.com
Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …
The immunology of COVID-19: is immune modulation an option for treatment?
J Zhong, J Tang, C Ye, L Dong - The Lancet Rheumatology, 2020 - thelancet.com
In December, 2019, an outbreak of COVID-19 emerged in Wuhan, China and quickly spread
globally. As of May 7, 2020, there were 3 672 238 confirmed infections and 254 045 deaths …
globally. As of May 7, 2020, there were 3 672 238 confirmed infections and 254 045 deaths …
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase …
L Shi, H Huang, X Lu, X Yan, X Jiang, R Xu… - Signal transduction and …, 2021 - nature.com
Abstract Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We
performed a phase 2 trial to assess the efficacy and safety of human umbilical cord …
performed a phase 2 trial to assess the efficacy and safety of human umbilical cord …
Mitochondrial transfer via tunneling nanotubes is an important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in …
MV Jackson, TJ Morrison, DF Doherty, DF McAuley… - Stem …, 2016 - academic.oup.com
Mesenchymal stromal cells (MSC) have been reported to improve bacterial clearance in
preclinical models of Acute Respiratory Distress Syndrome (ARDS) and sepsis. The …
preclinical models of Acute Respiratory Distress Syndrome (ARDS) and sepsis. The …
MSC therapies for COVID-19: importance of patient coagulopathy, thromboprophylaxis, cell product quality and mode of delivery for treatment safety and efficacy
Numerous clinical trials of mesenchymal stromal/stem cells (MSCs) as a new treatment for
coronavirus-induced disease (COVID-19) have been registered recently, most of them …
coronavirus-induced disease (COVID-19) have been registered recently, most of them …
Differences and similarities between cancer and somatic stem cells: therapeutic implications
F Rossi, H Noren, R Jove, V Beljanski… - Stem cell research & …, 2020 - Springer
Over the last decades, the cancer survival rate has increased due to personalized therapies,
the discovery of targeted therapeutics and novel biological agents, and the application of …
the discovery of targeted therapeutics and novel biological agents, and the application of …
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions
M Di Trapani, G Bassi, M Midolo, A Gatti… - Scientific reports, 2016 - nature.com
Mesenchymal stromal cells (MSCs) are multipotent cells, immunomodulatory stem cells that
are currently used for regenerative medicine and treatment of a number of inflammatory …
are currently used for regenerative medicine and treatment of a number of inflammatory …
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
CJ Rogers, RJ Harman, BA Bunnell… - Journal of translational …, 2020 - Springer
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …
province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per …
Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
K **ao, F Hou, X Huang, B Li, ZR Qian, L **e - Stem Cell Research & …, 2020 - Springer
Acute respiratory distress syndrome (ARDS) develops rapidly and has a high mortality rate.
Survivors usually have low quality of life. Current clinical management strategies are …
Survivors usually have low quality of life. Current clinical management strategies are …
Mesenchymal stromal cell therapy for liver diseases
The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver
fibrosis is predominantly based on their immunosuppressive properties, and their ability to …
fibrosis is predominantly based on their immunosuppressive properties, and their ability to …